Innovative and Sustainable in a Network
Röhm Strives for Global Technology Leadership as a Methacrylate Specialist.
News
15.10.2024 • News
Solvay Completes Major GHG Emissions-Reduction Project in the US
Solvay has inaugurated its regenerative thermal oxidation (RTO) process at its US plant at Green River, Wyoming. The innovative emissions control technology, which Solvay claims is the first of its kind in the trona mining industry, is expected to help reduce greenhouse gas emissions at the plant by up to 20% annually and achieve a 4% reduction in emissions at group level by 2025.
14.10.2024 • News
Mestag Signs License and Research Deal with Merck & Co.
Mestag Therapeutics, a Cambridge, UK-headquartered biotech company working on new insights into fibroblast-immune interactions, has signed a license and collaboration agreement with US drugmaker Merck & Co., known as MSD outside of North America, to identify novel targets for the development of therapies against inflammatory diseases.
14.10.2024 • News
Sudarshan Chemical Agrees to Acquire Heubach Group
Sudarshan Chemical Industries Limited (SCIL) recently announced that it has entered into a definitive agreement with the Germany-based Heubach Group, on its acquisition in a combination of an asset and share deal. Sudarshan aims to expand its global presence and pigment portfolio across 19 sites to provide customers with a top-tier product range.
14.10.2024 • News
Honeywell Plans to Spin Off Its Advanced Materials Business
In a move to progress its strategic priorities of accelerating organic growth, Honeywell announced that it plans to spin off its Advanced Materials business into an independent, US publicly traded company. The spin-off, which is expected to be tax-free to its shareholders, is likely to be completed by the end of next year or early 2026, subject to certain customary conditions.
11.10.2024 • News
Specialty Pharma CDMO OneSource Recently Launched
OneSource Specialty Pharma, a newly incorporated CDMO, formed from the merger of three CDMO businesses within the Strides Group. The company has a 30-year track record and specializes in biologics, drug-device combinations, and soft gelatin capsules.
10.10.2024 • News
Rio Tinto to Acquire Arcadium Lithium for $6.7 Billion
Rio Tinto announced that it will acquire Arcadium Lithium in an all-cash transaction for $5.85 per share that values Arcadium’s at approximately $6.7 billion.
04.10.2024 • News
Piramal to Expand US Facility for Sterile Injectables
US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for the expansion of its Lexington, Kentucky, facility.
03.10.2024 • News • Bioprocessing
Lilly Announces New $4.5 Billion Site
Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.
03.10.2024 • News
SK Pharmteco to Expand Production in South Korea
South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new facility in Sejong, South Korea.
02.10.2024 • News
A.P. Moller Holding Launches Fossil-free Plastic Resins Business
A.P. Moller Holding, the mother company of shipping giant Maersk, has launched Vioneo, a manufacturer of fossil-free plastic resins and intends to establish its first production complex in Antwerp, Belgium. The plant, in which Vioneo plans to invest €1,5 billion, will benefit from the region’s expertise in the chemicals industry, strong export facilities and access to renewable energy, the company said.
02.10.2024 • News
Evonik Breaks Ground on Major Silica Expansion in Charleston, US
Evonik recently announced the groundbreaking of a significant expansion at its Charleston site in South Carolina’s Berkeley County.
02.10.2024 • News
Lonza Completes Acquisition of Vacaville Biologics Site from Roche
Lonza has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California, USA, from Roche for $1.2 billion. The deal was announced in March of this year.
01.10.2024 • News
Carbon Waters Opens its First Production Unit
Carbon Waters recently reached a major milestone with the installation of its first production unit at its facility in Pessac.
01.10.2024 • News
Air Products Completes Sale of its LNG Business to Honeywell for $1.8 Billion
Air Products recently completed the sale of its liquefied natural gas (LNG) process technology and equipment business to Honeywell for $1.81 billion (€1.63 billion) in cash.
30.09.2024 • News
Boehringer Ingelheim Expands Cancer Research at Vienna Site
On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.
26.09.2024 • News
Cambrex Announces New Peptide Synthesis Manufacturing Technology
Cambrex announced that Snapdragon Chemistry, a Cambrex company, has developed a new liquid-phase peptide synthesis (LPPS) technology utilizing active pharmaceutical ingredient (API) batch reactors and continuous flow.
26.09.2024 • News
Azelis Acquires Polish Specialty Chemicals Distributor Hortimex
Azelis has signed an agreement to acquire 100% of the shares of Hortimex, a specialty chemicals distributor active in the food ingredients and nutraceuticals segments serving the Polish market.
25.09.2024 • News
ECI Group Secures First 150kta Copolymer License
ECI Group recently announced the signing of a licensing agreement with Shaanxi Yanchang China Coal Yulin Energy & Chemical Co., Ltd. (YECC) to deliver a 150kta copolymer plant project using ECI Group’s proprietary hybrid reactor technology.
24.09.2024 • News • Bioprocessing
Lonza and Vertex Sign a Commercial Supply Agreement for Casgevy
Lonza and Vertex Pharmaceuticals recently announced a commercial supply agreement for casgevy (exagamglogene autotemcel).
20.09.2024 • News
Lonza Launches Innovaform Accelerator
Lonza inaugurated its new facility at the Colmar, France site. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
19.09.2024 • News
Covestro to Build New TPU Center in China
Covestro will start the construction of a new Thermoplastic Polyurethanes (TPU) APAC Application Development (AD) Center in Guangzhou, China.
18.09.2024 • News
AI Specialist COAC to Lead Shell’s Smart Equipment Passport Initiative
In collaboration with Shell, COAC has implemented the Smart Equipment Passport (SEP), a solution to create digital identities of equipment that can be used to exchange information with internal and external users safely and securely.
17.09.2024 • News
Bilfinger Secures Major Contract with Egyptian Chemical Industries
Bilfinger is broadening its presence in Egypt by securing a substantial Project Management and Consultancy (PMC) contract from Egyptian Chemical Industries (KIMA).
13.09.2024 • News
Ucaneo Secures Seed Funding
Ucaneo, a provider of innovative direct air capture (DAC) technologies for CO2 removal, has raised €6.75 million in seed funding including grants.
13.09.2024 • News
Egrobots – New Technologies for a more Sustainable Agriculture
Egrobots, a start-up from Egypt, developed a solution for efficient farm monitoring and management using AI and robotics. Their innovation includes an autonomous robot, that roams around the farm, scanning the plants on a leaf-level with high resolution and an AI that analyses this data.
11.09.2024 • News
Nouryon Begins Operations in Mato Grosso do Sul, Brazil
Nouryon recently announced it has commenced operations at its new Integrated Manufacturing Model site in Ribas do Rio Pardo, Mato Grosso do Sul, Brazil, which includes the production of hydrogen peroxide, sodium chlorate, and chlorine dioxide.
11.09.2024 • News
Denmark’s First CO2 Storage Facility Now Operational
Denmark’s North Sea subsoil now hosts a safe and efficient CO2 storage facility, thanks to Project Greensand. The 23 partners have successfully completed the pilot phase, demonstrating the project’s viability and readiness.
Flow Chemistry in Drug Discovery
For the synthesis of compounds in pharmaceutical applications, it is important to select the most appropriate flow chemistry regime and equipment based on the goals of the application.
11.09.2024 • News • Innovation
World’s Most Comprehensive Protein Search Engine
Interview with Johannes Kabisch (CSO), Joe Heenan (CEO) and Aron Eiermann (CTO), Proteineer
11.09.2024 • News • Innovation
The Subscription Revolution in Flow Chemistry
Interview with Sridhar Balaram, Founder and CEO of Flownetics Engineering.
11.09.2024 • News • Bioprocessing
Minicircle DNA
The minicircle has emerged as a Next Generation Gene Vector and as a promising tool in the field of gene delivery and therapeutic applications. This overview aims to cover the characteristics, production methods, and potential applications of minicircle DNA.
Europe’s Biotech Cluster Powerhouses
Cambridge, Leiden, Heidelberg or Paris - many European countries have biotechnology clusters in which scientific expertise meets a well-developed infrastructure, committed entrepreneurship and attractive financing opportunities. A subjective look at the best.
The CDMO/CMO Report
Driven by increased demand in biologic-based drugs, biologic drug substance manufacturing continues to be an active area of investment by contract development and manufacturing organizations/contract manufacturing organizations (CDMOs/CMOs), including several multi-billion large-scale biomanufacturing projects. What companies are expanding, and where do these expansions stand?
Pharma’s Digital Transformation
Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team – explain the transformational challenges and critical success factors of the digital Pharma 4.0 journey.
